Streamex Corp.
Business
Streamex Corp. operates two principal business lines: Tokenized Asset Finance, providing blockchain-based digitization and trading infrastructure for real-world assets including tokenized gold (GLDY) via its Streamex Exchange platform, and Biomedical Technology, delivering advanced signal processing for cardiac electrophysiology procedures via its PURE EP™ platform. The company also holds majority interests in ViralClear Pharmaceuticals and BioSig AI Sciences, both currently inactive.
Summary from 10-K filed 2026-03-31
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | — | 40,000 | 18,000 | — | — | |
| Research and development | 31,000 | 800,000 | 5 | 6 | 6 | |
| General and administrative | 68 | 12 | 23 | 21 | 28 | |
| Impairment of long term assets | — | 253,000 | — | — | — | |
| Depreciation and amortization | 4 | 188,000 | 361,000 | — | — | |
| Total operating expenses | 71 | 13 | 29 | 27 | 34 | |
| Loss from operations | −71 | −13 | −29 | −27 | −33 | |
| Interest expense, net | −2 | −11,000 | 9,000 | 3,000 | 2,000 | |
| Change in fair value of marketable securities | −777,000 | — | — | — | — | |
| Loss on warrant settlement | −8 | — | — | — | — | |
| Change in fair value of derivative liability | −390 | — | — | — | — | |
| Change in fair value of embedded derivative | 7 | — | — | — | — | |
| Gain on settlement and forgiveness of accounts payable and other liabilities | 196,000 | 3 | — | — | — | |
| Other income (expense), net: | −33,000 | 23,000 | −187,000 | — | — | |
| Total other income (expense), net | −393 | 3 | — | — | — | |
| Loss before income taxes | −464 | −10 | −29 | −27 | −33 | |
| Income taxes (benefit) | −1 | — | — | — | 0 | |
| Net loss | −463 | −10 | −29 | −27 | −33 | |
| Non-controlling interest | −15,000 | 9,000 | −351,000 | 210,000 | 939,000 | |
| Net loss attributable to Streamex Corp. | −463 | −10 | −29 | −27 | −32 | |
| Preferred stock dividend | −11,000 | −9,000 | −9,000 | −9,000 | −9,000 | |
| Preferred stock deemed dividend | — | −174,000 | — | −210,000 | 0 | |
| Net loss attributed to Streamex Corp. Common Shareholders | −463 | −11 | −29 | −27 | −32 | |
| Net loss per common share, basic | −9.65 | −0.75 | −3.95 | −6.33 | — | |
| Net loss per common share, diluted | −9.65 | −0.75 | −3.95 | −6.33 | — | |
| Weighted average number of common shares outstanding, basic | 48 | 14 | 7 | 4 | — | |
| Weighted average number of common shares outstanding, diluted | 48 | 14 | 7 | 4 | — | |
| Change in foreign currency translation adjustments | 814,000 | — | — | — | — | |
| Total comprehensive loss | −462 | −10 | — | — | — | |
| Comprehensive (loss) income attributable to non-controlling interest | −15,000 | 9,000 | — | — | — | |
| Comprehensive (loss) income attributable to Streamex Corp. | −462 | −10 | — | — | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2023 2023-01-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|---|
| Cash | 20 | 142,000 | 190,000 | — | 357,000 | |
| Accounts receivable | — | 109,000 | 24,000 | — | 9,000 | |
| Sales tax receivable | 51,000 | — | — | — | — | |
| Net investment in leases, short term | — | 13,000 | 103,000 | — | 101,000 | |
| Marketable securities | 10 | — | — | — | — | |
| Prepaid expenses and other assets | 17 | 124,000 | 206,000 | — | 325,000 | |
| Total current assets | 72 | 388,000 | 528,000 | — | 1 | |
| Property and equipment, net | 25,000 | 85,000 | 509,000 | — | 665,000 | |
| Right-to-use assets, net | — | 96,000 | 412,000 | 41,227 | 705,000 | |
| Net investment in leases, long term | — | 4,000 | 17,000 | — | 120,000 | |
| Intangible assets, net | 45 | 269,000 | — | — | — | |
| Goodwill | 71 | — | — | — | — | |
| Total non-current assets | 116 | 454,000 | — | — | — | |
| Total assets | 188 | 842,000 | 2 | — | 4 | |
| Accounts payable and accrued expenses, including $66 and $19 to related parties as of December 31, 2025 and 2024, respectively. | 3 | 2 | 4 | — | 3 | |
| Dividends payable | 121,000 | 110,000 | 101,000 | — | 91,000 | |
| Convertible notes payable | 38 | — | — | — | — | |
| Embedded derivative liability | 2 | — | — | — | — | |
| Lease liability, short term | — | 102,000 | 349,000 | — | 313,000 | |
| Total current liabilities | 43 | 2 | 5 | — | 3 | |
| Deferred tax liability | 11 | — | — | — | — | |
| Total liabilities | 54 | 2 | 5 | — | 4 | |
| Commitments and contingencies (Note 10) | — | — | — | — | — | |
| Redeemable Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; (liquidation preference of $105; cumulative dividends payable of $121 and $110 as of December 31, 2025 and 2024, respectively). | 105,000 | 105,000 | 105,000 | — | 105,000 | |
| Preferred stock, $0.001 par value, authorized 1,000,000 shares, designated 200 shares of Series A, 600 shares of Series B, 4,200 shares of Series C, 1,400 shares of Series D, 1,000 shares of Series E, 200,000 shares of Series F Preferred Stock and 1 Special Voting Preferred Stock. | — | — | — | — | — | |
| Common stock, $0.001 par value, authorized 500,000,000 shares, 49,805,275 and 17,239,096 issued and outstanding as of December 31, 2025 and 2024, respectively. | 50,000 | 17,000 | 9,000 | — | 5,000 | |
| Additional paid-in-capital | 850 | 254 | 242 | — | 216 | |
| Accumulated other comprehensive income | 814,000 | — | — | — | — | |
| Accumulated deficit | −718 | −255 | −245 | — | −216 | |
| Total stockholders equity (deficit) attributable to Streamex Corp. | 133 | −2 | −3 | — | 313,000 | |
| Non-controlling interest | 32,000 | 17,000 | 26,000 | — | −21,000 | |
| Total stockholders equity (deficit) | 133 | −2 | −3 | — | 292,000 | |
| Total liabilities and stockholders equity (deficit) | 188 | 842,000 | 2 | — | 4 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Amortization of debt discount and issuance costs | 1 | — | — | — | — | |
| Gain on settlement and forgiveness of accounts payable and other liabilities | −196,000 | −3 | — | — | — | |
| Non-cash lease expense | 96,000 | 316,000 | 293,000 | — | — | |
| Change in fair value of exchangeable shares derivative liability | 390 | — | — | — | — | |
| Change in fair value of convertible debenture embedded derivative | −7 | — | — | — | — | |
| Fair value of liability warrants reclassified from permanent equity | 8 | — | — | — | — | |
| Stock based compensation expense | 57 | 7 | 8 | 4 | 10 | |
| Deferred income taxes | −1 | — | — | — | — | |
| Allowance for credit losses on accounts receivable | 109,000 | — | — | — | — | |
| Accounts receivable | — | −85,000 | −15,000 | −9,000 | 0 | |
| Lease receivables | — | 103,000 | 101,000 | −220,000 | 0 | |
| Sales tax receivable | −36,000 | — | — | — | — | |
| Employee advances | — | 5,000 | −5,000 | — | — | |
| Change in net investment in leases | 13,000 | — | — | — | — | |
| Prepaid expenses and other assets | −405,000 | 126,000 | — | 30,000 | −50,000 | |
| Customer deposits | — | −7,000 | 16,000 | — | — | |
| Accounts payable and accrued expenses | 597,000 | 571,000 | 1 | 776,000 | — | |
| Operating lease liabilities | −102,000 | −350,000 | −313,000 | — | — | |
| Net cash used in operating activities | −10 | −5 | −17 | −22 | −26 | |
| Purchase of investment | −144,000 | — | — | — | — | |
| Purchase of gold held as long-term investment | −24 | — | — | — | — | |
| Business acquisition, net of cash acquired | 366,000 | — | — | — | — | |
| Net cash used in investing activity | −24 | — | −186,000 | −168,000 | −542,000 | |
| Sale of common stock under at-the- market offering, net of transaction costs | 17 | — | — | — | — | |
| Sale of common stock and warrants | 818,000 | 4 | — | 2 | 1 | |
| Repayment of finance obligation | −712,000 | — | — | — | — | |
| Proceeds from convertible note payable, net of issuance costs | 45 | — | — | — | — | |
| Cash paid to settle warrants | −8 | — | — | — | — | |
| Proceeds from issuance of related party note payable | — | 500,000 | — | — | — | |
| Net cash provided by financing activities | 55 | 5 | 17 | 11 | 10 | |
| Effect of exchange rate change on cash | −15,000 | — | — | — | — | |
| Net increase in cash | 20 | −48,000 | — | — | — | |
| Cash paid during the year for interest | — | — | 1,000 | — | 0 | |
| Cash paid during the year for income taxes | — | — | — | — | — | |
| Recognition of derivative liability as part of business combination | 105 | — | — | — | — | |
| Recognition of assets acquired as part of business combination | 118 | — | — | — | — | |
| Recognition of liabilities assumed as part of business combination | 13 | — | — | — | — | |
| Common stock issued in settlement of accounts payable and accrued expenses | 683,000 | 122,000 | — | — | — | |
| Dividend payable on preferred stock charged to additional paid-in-capital | 11,000 | 9,000 | 9,000 | — | — | |
| Financing obligation entered into in exchange for prepaid insurance | 2 | — | — | — | — | |
| Prepaid stock based compensation | 15 | — | — | — | — | |
| Investment in Empress Royalty Corp. acquired through issuance of common stock | 10 | — | — | — | — | |
| Common stock issued in settlement of accrued severance | — | 45,000 | — | — | — | |
| Series C convertible preferred stock deemed dividend | — | 174,000 | — | 210,000 | — | |
| Common stock issued for conversion of note payable and accrued interest | — | 509,000 | — | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Streamex Corp.'s CIK number?
Streamex Corp.'s SEC CIK number is 0001530766 (1530766). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Streamex Corp.'s SEC filings?
All of Streamex Corp.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.